Design of modular autoproteolytic gene switches responsive to anti-coronavirus drug candidates
SARS-CoV-2 proteases are key targets for anti-viral drug development. Here the authors present modular tunable autoproteolytic gene switches for virus free cell culture screening of inhibitors.
Enregistré dans:
Auteurs principaux: | Nik Franko, Ana Palma Teixeira, Shuai Xue, Ghislaine Charpin-El Hamri, Martin Fussenegger |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b5aed737c2c545b2be5f551a0d14a25f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Caffeine-inducible gene switches controlling experimental diabetes
par: Daniel Bojar, et autres
Publié: (2018) -
Medicinal plants: Prospective drug candidates against the dreaded Coronavirus
par: Emmanuel Onah Ojah
Publié: (2020) -
Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson’s disease treatment
par: Ryosuke Kojima, et autres
Publié: (2018) -
MYRF is a membrane-associated transcription factor that autoproteolytically cleaves to directly activate myelin genes.
par: Helena Bujalka, et autres
Publié: (2013) -
CARD8 and NLRP1 undergo autoproteolytic processing through a ZU5-like domain.
par: Andrea D'Osualdo, et autres
Publié: (2011)